Search research articles
Contact Us
Filters
Showing results (71-80 of 102) with videos related to
Page
of 11
Sort By:
Cell Reports
|
June 24, 2021
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
Adi Nagler, Shelly Kalaora, Chaya Barbolin, et al.
Pigment Cell & Melanoma Research
|
May 9, 2009
Frequent mutations in the MITF pathway in melanoma
Julia C Cronin, John Wunderlich, Stacie K Loftus, et al.
Cell Reports
|
June 2, 2015
Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation
Hyungsoo Kim, Dennie T Frederick, Mitchell P Levesque, et al.
The Journal of Investigative Dermatology
|
September 7, 2013
Somatic mutations in MAP3K5 attenuate its proapoptotic function in melanoma through increased binding to thioredoxin
Todd D Prickett, Brad Zerlanko, Jared J Gartner, et al.
Plos Genetics
|
August 23, 2012
Mutational signatures of de-differentiation in functional non-coding regions of melanoma genomes
Stephen C J Parker, Jared Gartner, Isabel Cardenas-Navia, et al.
Nature Communications
|
July 10, 2018
Assembly and activation of the Hippo signalome by FAT1 tumor suppressor
Daniel Martin, Maria S Degese, Lynn Vitale-Cross, et al.
Nature Communications
|
July 1, 2018
Harnessing synthetic lethality to predict the response to cancer treatment
Joo Sang Lee, Avinash Das, Livnat Jerby-Arnon, et al.
Scientific Reports
|
March 10, 2019
Author Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells
Nouar Qutob, Ikuo Masuho, Michal Alon, et al.
Nature Communications
|
June 21, 2016
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
Yujun Hao, Yardena Samuels, Qingling Li, et al.
Scientific Reports
|
January 14, 2018
RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells
Nouar Qutob, Ikuo Masuho, Michal Alon, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 102) with videos related to
Sort By:
Page
of 11
Cell Reports
|
June 24, 2021
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
Adi Nagler, Shelly Kalaora, Chaya Barbolin, et al.
Pigment Cell & Melanoma Research
|
May 9, 2009
Frequent mutations in the MITF pathway in melanoma
Julia C Cronin, John Wunderlich, Stacie K Loftus, et al.
Cell Reports
|
June 2, 2015
Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation
Hyungsoo Kim, Dennie T Frederick, Mitchell P Levesque, et al.
The Journal of Investigative Dermatology
|
September 7, 2013
Somatic mutations in MAP3K5 attenuate its proapoptotic function in melanoma through increased binding to thioredoxin
Todd D Prickett, Brad Zerlanko, Jared J Gartner, et al.
Plos Genetics
|
August 23, 2012
Mutational signatures of de-differentiation in functional non-coding regions of melanoma genomes
Stephen C J Parker, Jared Gartner, Isabel Cardenas-Navia, et al.
Nature Communications
|
July 10, 2018
Assembly and activation of the Hippo signalome by FAT1 tumor suppressor
Daniel Martin, Maria S Degese, Lynn Vitale-Cross, et al.
Nature Communications
|
July 1, 2018
Harnessing synthetic lethality to predict the response to cancer treatment
Joo Sang Lee, Avinash Das, Livnat Jerby-Arnon, et al.
Scientific Reports
|
March 10, 2019
Author Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells
Nouar Qutob, Ikuo Masuho, Michal Alon, et al.
Nature Communications
|
June 21, 2016
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
Yujun Hao, Yardena Samuels, Qingling Li, et al.
Scientific Reports
|
January 14, 2018
RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells
Nouar Qutob, Ikuo Masuho, Michal Alon, et al.
Page
of 11